Erreni M. et al., demonstrate that CX3CR1 mRNA and protein levels were equally expressed in low- and high-grade tumors, whereas CX3CL1 (fractalkine) was found in oligodendrogliomas, anaplastic astrocytomas, and glioblastomas. Here, CX3CL1 is linked to glioblastoma.